Academic drug discovery centres: the economic and organisational sustainability of an emerging model

被引:15
作者
Kirkegaard, Henriette Schultz [1 ]
Valentin, Finn [2 ]
机构
[1] Danish Med Device Ind Assoc, DK-2990 Niva, Denmark
[2] Copenhagen Business Sch, Res Ctr Biotech Business, DK-2000 Frederiksberg, Denmark
基金
英国惠康基金; 美国国家卫生研究院;
关键词
INDUSTRY; INNOVATION; SCIENCE; VALLEY; DEATH; US;
D O I
10.1016/j.drudis.2014.06.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.
引用
收藏
页码:1699 / 1710
页数:12
相关论文
共 31 条
[1]  
Arora A., 2001, Markets for technology and their implications for corporate strategy
[2]   Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups [J].
Baum, JAC ;
Silverman, BS .
JOURNAL OF BUSINESS VENTURING, 2004, 19 (03) :411-436
[3]   Fundamental problems lie ahead in the drug discovery and commercialization process: Restructuring of the pharmaceutical industry and an improved partnership with academia are required [J].
Brewer, George J. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (06) :291-302
[4]  
DASGUPTA P, 1994, RES POLICY, V23, P487
[5]   The Alabama Drug Discovery Alliance: A Collaborative Partnership to Facilitate Academic Drug Discovery [J].
Everts, Maaike ;
Knight, W. Blaine ;
Harris, David R. ;
Secrist, John A., III ;
Whitley, Richard J. .
PHARMACEUTICAL RESEARCH, 2011, 28 (07) :1454-1459
[6]   Bridging the Valley of Death of therapeutics for neurodegeneration [J].
Finkbeiner, Steven .
NATURE MEDICINE, 2010, 16 (11) :1227-1232
[7]   Drug discovery in academia: the third way? [J].
Frearson, Julie ;
Wyatt, Paul .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (10) :909-919
[8]   HTS and hit finding in academia - from chemical genomics to drug discovery [J].
Frearson, Julie A. ;
Collie, Iain T. .
DRUG DISCOVERY TODAY, 2009, 14 (23-24) :1150-1158
[9]  
Freeman MW, 2011, J INVEST MED, V59, P746, DOI 10.2310/JIM.0b013e3182160d70
[10]   US academic drug discovery [J].
Frye, Stephen ;
Crosby, Marina ;
Edwards, Teresa ;
Juliano, Rudolph .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) :409-410